171 related articles for article (PubMed ID: 15750198)
21. Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis.
Cianchi F; Cuzzocrea S; Vinci MC; Messerini L; Comin CE; Navarra G; Perigli G; Centorrino T; Marzocco S; Lenzi E; Battisti N; Trallori G; Masini E
Dig Liver Dis; 2010 Jan; 42(1):20-7. PubMed ID: 19497798
[TBL] [Abstract][Full Text] [Related]
22. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
23. Interaction between cyclooxygenase-2 and inducible nitric oxide synthase in gastric cancer.
Son HJ; Kim YH; Park DI; Kim JJ; Rhee PL; Paik SW; Choi KW; Song SY; Rhee JC
J Clin Gastroenterol; 2001; 33(5):383-8. PubMed ID: 11606854
[TBL] [Abstract][Full Text] [Related]
24. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.
Cianchi F; Cortesini C; Fantappiè O; Messerini L; Schiavone N; Vannacci A; Nistri S; Sardi I; Baroni G; Marzocca C; Perna F; Mazzanti R; Bechi P; Masini E
Am J Pathol; 2003 Mar; 162(3):793-801. PubMed ID: 12598314
[TBL] [Abstract][Full Text] [Related]
25. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression.
Soo R; Putti T; Tao Q; Goh BC; Lee KH; Kwok-Seng L; Tan L; Hsieh WS
Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):147-52. PubMed ID: 15723947
[TBL] [Abstract][Full Text] [Related]
27. [Expression of cyclooxygenase-2 and inducible nitric oxide synthase in tongue hyperplasia and tongue squamous cell carcinoma].
Xu GX; Chen WL; Li HG; Li JS; Yang CH; Pan CB
Ai Zheng; 2005 Nov; 24(11):1345-9. PubMed ID: 16552960
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers.
Toyoki H; Fujimoto J; Sato E; Sakaguchi H; Tamaya T
Ann Oncol; 2005 Jan; 16(1):51-5. PubMed ID: 15598938
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis.
Lin Z; Chen S; Ye C; Zhu S
Urol Res; 2003 Aug; 31(4):232-5. PubMed ID: 12937869
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer.
Uotila P; Valve E; Martikainen P; Nevalainen M; Nurmi M; Härkönen P
Urol Res; 2001 Feb; 29(1):23-8. PubMed ID: 11310211
[TBL] [Abstract][Full Text] [Related]
31. Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.
Sun MH; Han XC; Jia MK; Jiang WD; Wang M; Zhang H; Han G; Jiang Y
World J Gastroenterol; 2005 Oct; 11(38):5931-7. PubMed ID: 16273602
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
[TBL] [Abstract][Full Text] [Related]
33. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
34. Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer.
Kong G; Kim EK; Kim WS; Lee YW; Lee JK; Paik SW; Rhee JC; Choi KW; Lee KT
Int J Pancreatol; 2001; 29(3):133-40. PubMed ID: 12067216
[TBL] [Abstract][Full Text] [Related]
35. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
[TBL] [Abstract][Full Text] [Related]
36. Relationship between inducible nitric oxide synthase expression and angiogenesis in primary gallbladder carcinoma tissue.
Niu XJ; Wang ZR; Wu SL; Geng ZM; Zhang YF; Qing XL
World J Gastroenterol; 2004 Mar; 10(5):725-8. PubMed ID: 14991947
[TBL] [Abstract][Full Text] [Related]
37. The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma.
Uotila PJ; Erkkola RU; Klemi PJ
Ann Med; 2002; 34(6):428-33. PubMed ID: 12523498
[TBL] [Abstract][Full Text] [Related]
38. Expression of beta-catenin, COX-2 and iNOS in colorectal cancer: relevance of COX-2 adn iNOS inhibitors for treatment in Malaysia.
Hong SK; Gul YA; Ithnin H; Talib A; Seow HF
Asian J Surg; 2004 Jan; 27(1):10-7. PubMed ID: 14719508
[TBL] [Abstract][Full Text] [Related]
39. Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma.
Ohno Y; Ohno S; Suzuki N; Kamei T; Inagawa H; Soma G; Inoue M
Int J Cancer; 2005 May; 114(5):696-701. PubMed ID: 15609300
[TBL] [Abstract][Full Text] [Related]
40. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
